Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 9, 2010
0
Date of Patent
June 3, 2014
0
Patent Application Number
13148420
0
Patent Citations Received
‌
US Patent 12089575 Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
0
‌
US Patent 11986466 Methods of treating solid tumors with CCR2 antagonists
0
‌
US Patent 11993653 Antibodies and methods of use thereof
0
‌
US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
0
‌
US Patent 11744822 Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
‌
US Patent 11753473 Anti-PD-L1 antibodies
‌
US Patent 11759454 Diazole lactams
‌
US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof
‌
US Patent 11932680 CD8A-binding fibronectin type III domains
0
Patent Inventor Names
Daniel Olive
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8741295
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0

Find more entities like US Patent 8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.